Axogen (AXGN) Total Debt Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Axogen | 2.00 Bn | 1.90 Bn | 46.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.60% |
| Sep 30, 2025 | 17.53% |
| Mar 31, 2025 | 74.21% |
| Dec 31, 2024 | 93.83% |
| Sep 30, 2024 | 65.78% |
| Jun 30, 2024 | 62.03% |
| Mar 31, 2024 | 59.16% |
| Dec 31, 2023 | 274.81% |
| Sep 30, 2023 | 262.32% |
| Jun 30, 2023 | 252.95% |
| Mar 31, 2023 | 16.13% |
| Dec 31, 2022 | 17.35% |
| Sep 30, 2022 | 13.31% |
| Jun 30, 2022 | 13.39% |
| Mar 31, 2022 | 13.18% |
| Dec 31, 2021 | 17.18% |
| Sep 30, 2021 | 13.09% |
| Jun 30, 2021 | 13.05% |
| Mar 31, 2021 | 5.32% |
| Dec 31, 2020 | 5.33% |
| Sep 30, 2020 | -3.41% |
| Mar 31, 2020 | -34.81% |
| Dec 31, 2019 | -41.38% |
| Sep 30, 2019 | -33.10% |
| Jun 30, 2019 | -31.16% |
| Mar 31, 2019 | -29.46% |
| Dec 31, 2018 | -69.87% |
| Sep 30, 2018 | -68.60% |
| Jun 30, 2018 | -67.54% |
| Mar 31, 2018 | -0.63% |
| Dec 31, 2017 | -0.98% |
| Sep 30, 2017 | 53.55% |
| Jun 30, 2017 | 37.78% |
| Mar 31, 2017 | 37.97% |
| Dec 31, 2016 | 33.20% |
| Sep 30, 2016 | 38.95% |
| Dec 31, 2015 | 28.39% |